| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |